Notable Analyst Rating Changes 5/21: TGT, FCX, CME, THC, CSIQ Upgraded; PETM, VALE, POT Downgraded

UPGRADES:
UBS upgrades Target (NYSE: TGT) from Neutral to Buy. Price target $52.

JP Morgan upgrades Freeport-McMoRan (NYSE: FCX) from Neutral to Overweight.

Goldman Sachs upgrades CME Group Inc. (NYSE: CME) from Neutral to Buy and raised its price target from $215 to $330.

Barclays upgrades Tenet Healthcare (NYSE: THC) from Equalweight to Overweight.

Oppenheimer upgrades Canadian Solar (Nasdaq: CSIQ) from Perform to Outperform. Price target $14.

For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades

DOWNGRADES:
Goldman Sachs downgrades PetSmart (Nasdaq: PETM) from Buy to Neutral.

Morgan Stanley downgrades Vale (Nasdaq: VALE) from Equalweight to Underweight.

TD Newcrest downgrades Potash Corp. of Saskatchewan (NYSE: POT) from Buy to Hold. Click here for more color.

For daily real-time Downgrades go to http://www.streetinsider.com/Downgrades

NEW COVERAGE:
Soleil Securities initiates coverage on Marriott International (NYSE: MAR) with a Buy. Price target $30.

William Blair initiates coverage on Perrigo (Nasdaq: PRGO) with an Outperform.

Soleil Securities initiates coverage on Priceline.com (Nasdaq: PCLN) with a Hold. Price target $112.

For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage

You May Also Be Interested In

• UPDATE: UBS Upgrades Morgan Stanley (MS) to Buy; Says Downside Already Priced In

Create E-mail Alert Related Categories

Special Reports

Related Entities

UBS, William Blair, JPMorgan, Goldman Sachs, Morgan Stanley, Soleil Securities, Barclays, TD Newcrest, Notable Analyst Rating Changes

Add Your Comment

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?

Follow StreetInsider.com On Twitter